CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Events Archives

Non-Pharmacological Interventions for Chronic Non-Cancer Pain: Physical Activity

September 23, 2020
Because of the prevalence and burden of chronic pain, health care providers are in search of the best multifaceted approach for treatment knowing that relying on opioids alone can be ineffective and carries substantial risks. Join CADTH for a webinar on the current evidence on physical activity for chronic, non-cancer pain. The target audience f...

Blood Plasma Therapies For COVID-19

August 25, 2020
With the COVID-19 pandemic showing no signs of slowing down, there’s a lot of interest in the global effort to develop a vaccine. Below the radar, researchers are exploring many other treatment options, including a century-old therapy that has been used to combat outbreaks of polio, measles, mumps, and influenza. Convalescent plasma therapy, whi...

Developing a COVID-19 Vaccine

August 12, 2020
The COVID-19 pandemic has disrupted our lives. Medical experts around the globe have said that what we each have known as normal life won’t fully resume until we have a vaccine, and that could take years. In this webinar, an expert panel will take you inside the race to develop a COVID-19 vaccine. What’s involved in developing a vaccine? Why doe...

Consultation on Drug Reviews: Webinar for Industry

July 20, 2020
Pharmaceutical companies and other stakeholders are invited to comment on a revised procedure for CADTH’s drug reimbursement review processes (that is, the pan-Canadian Oncology Drug Review, the Common Drug Review, the Interim Plasma Protein Product Review, and the Interim Process for Cell and Gene Therapies).  To help pharmaceutical compa...

Consultation on Drug Reviews: Webinar for Patient Groups

July 9, 2020
Patient groups and other stakeholders are invited to comment on a revised procedure for CADTH’s drug reimbursement review processes (that is, the pan-Canadian Oncology Drug Review, the Common Drug Review, and the Interim Plasma Protein Product Review).  To help patient groups and patients contribute to the consultation, this webinar will h...